Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study

Luana Fianchi; Matteo Bonanni; Alessandra Borchiellini; Federica Valeri; Gaetano Giuffrida; Stephanie Grasso; Claudio Fozza; Michele Ponta; Giovanni L Tiscia; Elvira Grandone; Nicola Vianelli; Alessandra Dedola; Teresa Pirozzi; Monica Sacco; Stefano Lancellotti; Raimondo De Cristofaro

doi:10.3390/jcm13216561

Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study

Luana Fianchi, Matteo Bonanni, Alessandra Borchiellini, Federica Valeri, Gaetano Giuffrida, Stephanie Grasso, Claudio Fozza, Michele Ponta, Giovanni L Tiscia, Elvira Grandone, Nicola Vianelli, Alessandra Dedola, Teresa Pirozzi, Monica Sacco, Stefano Lancellotti, Raimondo De Cristofaro^*

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	6561-6571
Numero di pagine	11
Rivista	Journal of Clinical Medicine
Volume	13
DOI	https://doi.org/10.3390/jcm13216561
Stato di pubblicazione	Pubblicato - 2024

Keywords

ADAMTS13
von Willebrand factor
thrombotic thrombocytopenic purpura
caplacizumab

Accesso al documento

10.3390/jcm13216561

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

Fianchi, L., Bonanni, M., Borchiellini, A., Valeri, F., Giuffrida, G., Grasso, S., Fozza, C., Ponta, M., Tiscia, G. L., Grandone, E., Vianelli, N., Dedola, A., Pirozzi, T., Sacco, M., Lancellotti, S., & De Cristofaro, R. (2024). Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study. Journal of Clinical Medicine, 13, 6561-6571. https://doi.org/10.3390/jcm13216561

@article{993e64e731094e448c01c9d49059b8e0,

title = "Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study",

keywords = "ADAMTS13, von Willebrand factor, thrombotic thrombocytopenic purpura, caplacizumab, ADAMTS13, von Willebrand factor, thrombotic thrombocytopenic purpura, caplacizumab",

author = "Luana Fianchi and Matteo Bonanni and Alessandra Borchiellini and Federica Valeri and Gaetano Giuffrida and Stephanie Grasso and Claudio Fozza and Michele Ponta and Tiscia, {Giovanni L} and Elvira Grandone and Nicola Vianelli and Alessandra Dedola and Teresa Pirozzi and Monica Sacco and Stefano Lancellotti and {De Cristofaro}, Raimondo",

year = "2024",

doi = "10.3390/jcm13216561",

language = "English",

volume = "13",

pages = "6561--6571",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

}

Fianchi, L, Bonanni, M, Borchiellini, A, Valeri, F, Giuffrida, G, Grasso, S, Fozza, C, Ponta, M, Tiscia, GL, Grandone, E, Vianelli, N, Dedola, A, Pirozzi, T, Sacco, M, Lancellotti, S & De Cristofaro, R 2024, 'Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study', Journal of Clinical Medicine, vol. 13, pagg. 6561-6571. https://doi.org/10.3390/jcm13216561

Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study. / Fianchi, Luana; Bonanni, Matteo; Borchiellini, Alessandra et al.
In: Journal of Clinical Medicine, Vol. 13, 2024, pag. 6561-6571.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study

AU - Fianchi, Luana

AU - Bonanni, Matteo

AU - Borchiellini, Alessandra

AU - Valeri, Federica

AU - Giuffrida, Gaetano

AU - Grasso, Stephanie

AU - Fozza, Claudio

AU - Ponta, Michele

AU - Tiscia, Giovanni L

AU - Grandone, Elvira

AU - Vianelli, Nicola

AU - Dedola, Alessandra

AU - Pirozzi, Teresa

AU - Sacco, Monica

AU - Lancellotti, Stefano

AU - De Cristofaro, Raimondo

PY - 2024

Y1 - 2024

KW - ADAMTS13

KW - von Willebrand factor

KW - thrombotic thrombocytopenic purpura

KW - caplacizumab

KW - ADAMTS13

KW - von Willebrand factor

KW - thrombotic thrombocytopenic purpura

KW - caplacizumab

UR - http://hdl.handle.net/10807/311876

U2 - 10.3390/jcm13216561

DO - 10.3390/jcm13216561

M3 - Article

SN - 2077-0383

VL - 13

SP - 6561

EP - 6571

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

ER -